tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Peter Verdult, 14 are a BUY (58.33%), 8 are a HOLD (33.33%), 2 are a SELL (8.33%).
Analyst Peter Verdult, currently employed at CITI, carries an average stock price target met ratio of 16.67% that have a potential upside of 3.48% achieved within 38 days.
Peter Verdult’s has documented 47 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 28-Jan-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 12/20/2021. The price target of $59.15 was fulfilled within 108 days with a profit of $9.35 (18.78%) receiving and performance score of 1.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$22
$-4.08 (-15.64%)
$31
17 days ago
(14-Feb-2025)
0/6 (0%)
$-3.44 (-13.52%)
Sell
$82.77
1 months 8 days ago
(23-Jan-2025)
2/7 (28.57%)
$-1.59 (-1.88%)
32
Hold
$30
$3.92 (15.03%)
$38
4 months 2 days ago
(01-Nov-2024)
11/14 (78.57%)
$3.11 (11.57%)
23
Sell
$31
$4.92 (18.87%)
$44
11 months 2 days ago
(01-Apr-2024)
6/9 (66.67%)
$-1.48 (-4.56%)
14
Hold
$40
11 months 24 days ago
(07-Mar-2024)
10/22 (45.45%)
$-2.36 (-5.57%)
73
Which stock is Peter Verdult is most bullish on?
What Year was the first public recommendation made by Peter Verdult?
